AxoGen, Inc. (AXGN)

AxoGen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-21.72	-28.95	-26.99	-23.79	-29.14
Depreciation & Amortization	5.55	4.85	4.74	3.46	2.88
Share-Based Compensation	14.42	15.59	10.92	8.47	10.3
Other Operating Activities	-3.97	-7.56	-2.08	2.23	-3.92
Operating Cash Flow	-5.72	-16.07	-13.41	-9.63	-19.87
Capital Expenditures	-13.87	-20.08	-27.81	-21.91	-4.66
Change in Investments	34.17	18.05	3.8	5.63	32.5
Other Investing Activities	-1.05	-1.18	0.36	-0.69	-0.56
Investing Cash Flow	19.25	-3.2	-23.65	-16.96	27.27
Share Issuance / Repurchase	1.96	1.81	5.47	6.8	4
Debt Issued / Paid	-0.01	-0.01	14.99	34.34	0.03
Other Financing Activities	-	-	-	-0.67	-
Financing Cash Flow	1.95	1.79	20.45	40.47	4.03
Net Cash Flow	15.49	-17.47	-16.6	13.89	11.43
Free Cash Flow	-19.59	-36.14	-41.22	-31.53	-24.54
Free Cash Flow Margin	-12.32%	-26.08%	-32.36%	-28.08%	-22.99%
Free Cash Flow Per Share	-0.46	-0.86	-1.00	-0.79	-0.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).